A group of 13 Chinese drug companies are appealing a ruling that upholds Pfizer's patent on Viagra. This dispute considered crucial to determining the country's position on counterfeit drugs and the global system of intellectual property rights that developers rely on to safeguard markets.
- read this Wall Street Journal report for more (sub. req.)